Vancouver, British Columbia — Eyecarrot Innovations Corp (TSX-V: EYC) is pleased to announce it has retained the services of Sigorex Management GmbH to provide investor relations services, subject to regulatory approval.
Sigorex, located in Kulmbach, Germany, is an independent investor relations agency with experience in the retail investor sector. They will initiate and maintain contact with the financial community, shareholders, investors and other stakeholders for the purpose of increasing awareness of the corporation and its activities. Sigorex will provide investor relations services to the corporation primarily throughout Europe.
“We look forward to working with Sigorex to actively engage the investment community in order communicate the Eyecarrot story, and lay the foundation for product success in Europe”
The agreement with Sigorex is effective immediately and has a term of 12 months. The corporation has agreed to pay Sigorex a fee of 5,000 euros per month, and issue 250,000 stock options, with a five (5) year term, and exercisable price of $1.62 per share. Sigorex has made an investment in Eyecarrot of $125,000 in the May 4th, 2015 financing.
The Company has also granted an aggregate of 4,250,000 options to Directors, Officers, Employees, and Consultants, having a five (5) year term and exercisable at a price of $1.62 per share.
Additionally, the corporation’s common shares have been quoted for trading on the Frankfurt Stock Exchange under the symbol 2EY, WKN #A14WN1.
Eyecarrot’s Binovitm platform is an innovative healthcare technology solution that integrates software, hardware, data and expert knowledge. Binovi helps Optometrists treat vision issues with in-office therapy as well as doctor led home based activities to better serve and increase the patient’s experience and their therapy needs. The goal is to help transform vision performance for the 1 in 4 people worldwide that suffer from vision-related issues going beyond visual acuity. The company is transforming how vision healthcare services are integrated, while addressing key challenges in the health system.
Forward Looking Information
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
source Eyecarrot Innovations Corp.